Form 4: Omada Health Director Granted Equity Compensation

Omada Health, Inc. Director Jeryl L. Hilleman received a grant of 1,601 restricted stock units on January 5, 2026, as part of the company's non-employee director compensation program.

Summary

• Jeryl L. Hilleman, a Director at Omada Health, Inc., was granted 1,601 restricted stock units (RSUs).
• The transaction occurred on January 5, 2026.
• These RSUs were granted in lieu of retainer fees under the Issuer's Non-Employee Director Compensation Program.
• Each RSU represents the right to receive one share of Common Stock.
• Following this transaction, Jeryl L. Hilleman beneficially owns 12,794 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a director, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not contain information that would significantly alter the company's financial outlook or operations.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders.
• Equity compensation is a common practice for non-employee directors, promoting long-term commitment.

Future Outlook

The settlement of the granted restricted stock units will occur either on a date selected by the reporting person or as otherwise provided by the Non-Employee Director Compensation Program.

Industry Context

Granting equity, such as restricted stock units, to non-employee directors is a standard practice across many industries, particularly in technology and healthcare, to attract and retain qualified board members and align their incentives with long-term company performance and shareholder value.

Comparison to Industry Standards

• The use of restricted stock units (RSUs) as a component of non-employee director compensation is a widely adopted practice, comparable to compensation structures seen at companies like Teladoc Health (TDOC) or Livongo Health (acquired by TDOC), which also utilize equity to incentivize board members.
• The structure of granting RSUs in lieu of cash retainer fees is a common method to conserve cash and reinforce an ownership mentality among directors, similar to practices observed in many growth-oriented tech and healthcare firms.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefits from increased alignment of director interests with long-term company performance.

Next Steps

• Settlement of the 1,601 restricted stock units into common stock shares.

Key Dates

Keywords

Omada Health, OMDA, Jeryl L. Hilleman, Director Compensation, Restricted Stock Units, RSUs, Insider Transaction, Equity Grant, Form 4, Corporate Governance